To report retinal vein occlusion (RVO) and age-related macular degeneration (AMD)-related
submacular hemorrhage developing after administration of SARS-CoV-2 vaccines, a single …

Introduction Published data on possible ocular adverse events potentially associated with
vaccination with the SARS-Cov-2 mRNA-1237 vaccine are scarce. In this report, we …

The reports of vascular adverse events in the eye following COVID-19 vaccination are
infrequent. We report the case of a healthy male who developed central retinal vein …

Abstract Coronavirus disease 2019 (COVID-19) is known to cause thromboembolic
episodes apart from acute respiratory distress syndrome (ARDS). With large vaccine drives …

Background: To describe cases of retinal vascular events shortly after administration of
mRNA or adenoviral-vectored COVID-19 vaccines. Design: Retrospective, multicenter case …

A central retinal vein occlusion (CRVO) case in a patient developed with sudden blurred
vision in some hemifield areas of his left eye, maintaining 20/20 vision 15-days after the …

Purpose We report 2 cases of ischemic retinal events occurring soon after administration of
the Moderna and Johnson & Johnson/Janssen COVID-19 vaccines. To our knowledge …

Purpose The purpose of this article is to report a case of sudden onset ischemic retinal
central vein occlusion after a second dose of COVID-19 adenoviral vector vaccine. Case …

Abstract A 28-year-old, healthy male presented with blurring of vision in the right eye
following third dose of the AstraZeneca/COVISHIELD vaccine. Further examination revealed …

Background Retinal vein occlusion (RVO) occurring after COVID-19 vaccination has been
reported worldwide. Such a sight-threatening condition occurring after COVID-19 …